At 30 dayspost-stroke, on the ischemic side of the brain, ISP treatment resulted inclearly increased numbers of DCX+ cells as well as their enhancedmigration toward the stroke penumbra but had no effect on the contralateral side(Figures 3B, 3C, 3F, and 3G, quantification in 3I). This evidence concerns the gene DCX and stroke disorder.